@InProceedings{Kaldoudi_EMBEC_2024,
author = {Kaldoudi, Eleni
and Marozas, Vaidotas
and Rytis, Jurkonis
and Pousset, Nicolas
and Legros, Mathieu
and Kircher, Marco
and Novikov, Dmitry
and Sakalauskas, Andrius
and Moustakidis, Pavlos
and Ayinde, Babajide
and Moltani, Lara Alessia
and Balling, Susann
and Vehkaoja, Antti
and Oksala, Niku
and Macas, Andrius
and Balciuniene, Neringa
and Bigaki, Maria
and Potoupnis, Michail
and Papadopoulou, Stella-Lida
and Grandone, Elvira
and Gautier, Maxime
and Bouda, Sabrina
and Schloetelburg, Cord
and Prinz, Thorsten
and Dionisio, Pietro
and Anagnostopoulos, Spyridon
and Drougka, Ioanna
and Folkvord, Frans
and Drosatos, George
and Didaskalou, Stylianos
and {The ThrombUS+ Consortium}},
editor = {Jarm, Toma{\v{z}}
and {\v{S}}merc, Rok
and Mahni{\v{c}}-Kalamiza, Samo},
title = {Towards Wearable Continuous Point-of-Care Monitoring for Deep Vein Thrombosis of the Lower Limb},
booktitle = {9th European Medical and Biological Engineering Conference},
year = {2024},
publisher = {Springer Nature Switzerland},
address = {Cham},
pages = {326--335},
doi = {10.1007/978-3-031-61628-0_36},
url = {https://doi.org/10.1007/978-3-031-61628-0_36},
abstract = {Deep vein thrombosis (DVT) is the formation of a blood clot within the deep veins, most commonly those of the lower limbs, causing obstruction of blood flow. In 50{\%} of people with DVT, the clot eventually breaks off and travels to the lung to cause pulmonary embolism. Clinical assessment of DVT is notoriously unreliable because up to 2/3 of DVT episodes are clinically silent and patients are symptom free even when pulmonary embolism has developed. Early diagnosis of DVT is crucial, and despite the progress made in ultrasound imaging and plethysmography techniques, there is a need for new methods to enable continuous monitoring of DVT at the point of care. This paper presents the conceptual design and methodology towards a novel wearable diagnostic device for point-of-care, operator-free, continuous monitoring in patients with high DVT risk. The device will combine novel wearable hardware for ultrasound imaging and impedance plethysmography with autonomous, AI driven DVT detection, to allow continuous monitoring for blood clot formation in the lower limb. Activity and other physiological measurements will be used to provide a continuous assessment of DVT risk and guide the automated scanning via an intelligent decision support unit that will provide accurate monitoring and alerts. The work is supported by the Horizon project ThrombUS+ co-funded by the European Union. (Grant Agreement No. 101137227).},
isbn = {978-3-031-61628-0}
}